sn-2 Palmitic Acid–A2 Beta-Casein Composition for Gut Health

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a need for nutritional compositions that reduce the presence of opportunistic pathogens while promoting beneficial bacteria to improve gut microbiota and overall gut health.

Innovation Solution

A combination of sn-2 palmitic acid and A2 beta-casein, along with other components, is used to synergistically reduce the relative abundance of disadvantageous Proteobacteria and increase beneficial bacterial families like Bacteroidaceae and Bifidobacteriaceae.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional formula feeding is used, then nutritional needs are met, but the gut microbiota becomes less beneficial compared to breast-fed babies

Engineering Contradiction:

Improvegut microbiota healthVSAvoidpresence of opportunistic pathogens

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the fatty acid composition parameters of the lipid component, specifically ensuring that at least 20% of total fatty acids are palmitic acid located at the sn-2 position of triglycerides. This parameter change in fat structure mimics breast milk composition and promotes beneficial microbiota while reducing harmful bacteria.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent uses a composite nutritional composition combining specific lipid components with defined fatty acid profiles and A2 beta-casein protein. This composite approach integrates multiple nutritional elements that work synergistically to improve gut microbiota composition and reduce opportunistic pathogens.

Inventive Principle:

Principle #40Composite materials

2Reliability

If high levels of Proteobacteria are present, then certain nutritional conditions are met, but inflammation and disease risk increase

Engineering Contradiction:

Improvereduction of inflammationVSAvoidProteobacteria abundance

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the potentially harmful effect of palmitic acid, which can sometimes promote inflammation when in wrong positions, into a beneficial effect by specifically placing it at the sn-2 position of triglycerides. This conversion reduces Proteobacteria and associated inflammation while maintaining nutritional value.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If sn-2 palmitic acid and A2 beta-casein are combined, then beneficial bacteria increase and Proteobacteria decrease, but formulation complexity increases

Engineering Contradiction:

Improvemicrobiota composition improvementVSAvoidcomposition formulation

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges sn-2 palmitic acid-containing lipids and A2 beta-casein into a single integrated nutritional composition. This combination creates a synergistic effect where the lipids and protein work together to reduce Proteobacteria and promote beneficial bacteria more effectively than either component alone.

Inventive Principle:

Principle #5Merging (Combining)

Data Source

PatentUS20250212929A1Nutritional composition

Publication Date: 2025.07.03 NV NUTRICIA

AI summary

A nutritional composition comprising sn-2 palmitic acid and A2 beta-casein for use in improving the gut microbiota in a human subject.